Discover open access scientific publications

Search, annotate, share and cite publications

Publications by KARI SYRJÄNEN

Patients With hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated With Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-Based Regimen

Anticancer Research

English

Correlation of Insulin-Like Growth Factor 1 Receptor Expression With Different Molecular Subtypes of Breast Cancer in the UAE

English

Related publications

Vascular Endothelial Growth Factor Polymorphisms and Clinical Outcome in Colorectal Cancer Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab

Pharmacogenomics Journal

English

Serum Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 Levels in Patients With Fibromyalgia Syndrome

Archives of Rheumatology

Rheumatology

2019

English

Vascular Endothelial Growth Factor Plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?

Journal of Oncology

Oncology

2009

English

Preoperative Vascular Endothelial Growth Factor Levels as a Prognostic Marker for Stage II or III Colorectal Cancer Patients

Cancer Growth and Metastasis

2011

English

Decreased Placental miR-126 Expression and Vascular Endothelial Growth Factor Levels in Patients With Pre-Eclampsia

Journal of International Medical Research

English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)

Dentistry

2011

English

Serum Levels of Vascular Endothelial Growth Factor and Transforming Growth Factor-.Beta.1 in Patients With Atrial Fibrillation Undergoing Defibrillation Therapy.

Japanese Heart Journal

2000

English

Thymidine Phosphorylase Expression Is Associated With Time to Progression in Patients With Metastatic Colorectal Cancer

BMC Clinical Pathology

English

Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients With Metastatic Colorectal Cancer Treated With Irinotecan and Cetuximab

Journal of Nuclear Medicine

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by KARI SYRJÄNEN

Patients With hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated With Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-Based Regimen

Correlation of Insulin-Like Growth Factor 1 Receptor Expression With Different Molecular Subtypes of Breast Cancer in the UAE

Related publications

Vascular Endothelial Growth Factor Polymorphisms and Clinical Outcome in Colorectal Cancer Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab

Serum Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 Levels in Patients With Fibromyalgia Syndrome

Vascular Endothelial Growth Factor Plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?

Preoperative Vascular Endothelial Growth Factor Levels as a Prognostic Marker for Stage II or III Colorectal Cancer Patients

Decreased Placental miR-126 Expression and Vascular Endothelial Growth Factor Levels in Patients With Pre-Eclampsia

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Serum Levels of Vascular Endothelial Growth Factor and Transforming Growth Factor-.Beta.1 in Patients With Atrial Fibrillation Undergoing Defibrillation Therapy.

Thymidine Phosphorylase Expression Is Associated With Time to Progression in Patients With Metastatic Colorectal Cancer

Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients With Metastatic Colorectal Cancer Treated With Irinotecan and Cetuximab